Last CR was @ 48c/share on 23/10/20 and prior to that, was 25/11/19. Both CRs to sophisticated investors, instos. The share price is now around 89c.
I can understand that retail shareholders got diluted as they could not participate in those CRs but the share price has doubled since as the business progressed. Perhaps, retail shareholders need a Share Purchase Plan(SPP) at next CR?
That Lab. generates about $3m p.a. which offsets a lot of the cash burn and hence, reduces the need for more CRs.
PIQ is a good biotech for long termers to hold in their portfolio, IMO.
Last CR was @ 48c/share on 23/10/20 and prior to that, was...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.0¢ |
Change
-0.020(2.22%) |
Mkt cap ! $115.1M | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 91.0¢ | 86.5¢ | $99.60K | 112.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8000 | 87.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 89.0¢ | 16900 | 1 |
View Market Depth
| Last trade - 15.54pm 28/06/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |